Q4 2024 Holdings
Filed 2025-02-14 | 2 holdings | $115.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Mineralys Therapeutics, Inc.(MLYS) | COM | 603170101 | $106.4M | 8,644,579 | 91.8% |
| Phathom Pharmaceuticals, Inc.(PHAT) | COM | 71722W107 | $9.5M | 1,167,114 | 8.2% |